Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuqiang Liu

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|August 21, 2015
Complement Inhibition: A Novel Form of Immunotherapy for Colon CancerStephanie Downs-Canner, Deepa Magge, Roshni Ravindranathan, et al.
Annals of Surgical Oncology|August 27, 2014
Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapyGuopei Luo, Meng Guo, Zuqiang Liu, et al.
Frontiers in Immunology|March 8, 2021
<i>In Vivo</i> Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell TherapyEsther Giehl, Hiromichi Kosaka, Zuqiang Liu, et al.
International Journal of Oncology|January 23, 2013
Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like propertiesGuopei Luo, Jiang Long, Xiaobo Cui, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 15, 2015
A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single centerGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Drug Design, Development and Therapy|March 10, 2015
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancerKaizhou Jin, Guopei Luo, Zhiwen Xiao, et al.
Cancer Letters|November 15, 2016
CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtypeGuopei Luo, Chen Liu, Meng Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2015
Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunityYi Zhang, Guo Chen, Zuqiang Liu, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapyZhi Zhu, Hongqi Chen, Chao Feng, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|August 21, 2015
Complement Inhibition: A Novel Form of Immunotherapy for Colon CancerStephanie Downs-Canner, Deepa Magge, Roshni Ravindranathan, et al.
Annals of Surgical Oncology|August 27, 2014
Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapyGuopei Luo, Meng Guo, Zuqiang Liu, et al.
Frontiers in Immunology|March 8, 2021
<i>In Vivo</i> Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell TherapyEsther Giehl, Hiromichi Kosaka, Zuqiang Liu, et al.
International Journal of Oncology|January 23, 2013
Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like propertiesGuopei Luo, Jiang Long, Xiaobo Cui, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 15, 2015
A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single centerGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2015
Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancerZuqiang Liu, Guopei Luo, Meng Guo, et al.
Drug Design, Development and Therapy|March 10, 2015
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancerKaizhou Jin, Guopei Luo, Zhiwen Xiao, et al.
Cancer Letters|November 15, 2016
CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtypeGuopei Luo, Chen Liu, Meng Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2015
Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunityYi Zhang, Guo Chen, Zuqiang Liu, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapyZhi Zhu, Hongqi Chen, Chao Feng, et al.
Pageof 8